Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

You might just know someone, close or distant, who has struggled with drug addiction at one point in time. It could be a distant relative or someone you went to school with, but the sheer probability ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...

If you are worried about using this medicine, speak to your doctor or pharmacist. INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat ...

The typical starting dosage ranges from 10 to 60 milligrams (mg) daily. Your doctor may adjust your dosage over the course of your treatment. The active ingredient in Prozac is fluoxetine.

Medications belonging to this family of drugs include: Oxybutynin: Available in tablet form (under its generic name) and transdermal patch (under brand name Oxytrol) Tolterodine: Available in tablet ...

Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart disease every 33 seconds. It remains the number one killer in the country. So it’s no ...

Sober when they arrived, Ms. Vlakos and her boyfriend were placed in a barely furnished two-bedroom apartment with a succession of strangers who often used drugs. She relapsed after a month.

Vitamin D dosage recommendations can vary depending on several factors, including your age, skin color, medical history, and where you live. Vitamin D is commonly known as the “sunshine vitamin.” ...

unsealed ruling shows Schizophrenia drug had nearly $3 billion in US sales in 2023 Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal judge that unexpected results and industry ...